A complementation method for functional analysis of mammalian genes

Nucleic Acids Research

Volumn 33, Issue 10, 2005, Pages 1-11

  Gonzalez Santos, Juana Maria ^a,c   Cao, Huibi ^a,c   Wang, Anan ^a   Koehler, David R ^a,c   Martin, Bernard ^a   Navab, Roya ^a,c   Hu, Jim ^a,b,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; COMPLEMENTARY DNA; SHORT HAIRPIN RNA; NUCLEAR PROTEIN; PRPF3 PROTEIN, HUMAN; SMALL NUCLEAR RIBONUCLEOPROTEIN;

ARTICLE; CELL LINE; DRUG SYNTHESIS; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; GENE TARGETING; GENETIC ANALYSIS; GENETIC CODE; GENETIC COMPLEMENTATION; HUMAN; HUMAN CELL; IN VIVO STUDY; MAMMALIAN GENETICS; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; RETINITIS PIGMENTOSA; RNA SPLICING; UNTRANSLATED REGION; WILD TYPE; ADENOVIRUS; GENE VECTOR; GENETICS; METABOLISM; METHODOLOGY; RNA INTERFERENCE; VALIDATION STUDY;

MAMMALIA;

ADENOVIRIDAE; CELL LINE; GENETIC COMPLEMENTATION TEST; GENETIC VECTORS; HUMANS; NUCLEAR PROTEINS; PHENOTYPE; RIBONUCLEOPROTEIN, U4-U6 SMALL NUCLEAR; RNA INTERFERENCE; RNA SPLICING;

EID: 23944491443     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gni093     Document Type: Article

References (45)

1. Lander,E.S., Linton,L.M., Birren,B., Nusbaum,C., Zody,M.C., Baldwin,J., Devon,K., Dewar,K., Doyle,M., FitzHugh,W. et al. (2001) Initial sequencing and analysis of the human genome. Nature, 409, 860-921.
2. Venter,J.C., Adams,M.D., Myers,E.W., Li,P.W., Mural,R.J., Sutton,G.G., Smith,H.O., Yandell,M., Evans,C.A., Holt,R.A. et al. (2001) The sequence of the human genome. Science, 291, 1304-1351.
3. Walhout,A.J., Boulton,S.J. and Vidal,M. (2000) Yeast two-hybrid systems and protein interaction mapping projects for yeast and worm. Yeast 17, 88-94.
4. Shoemaker,D.D., Schadt,E.E., Armour,C.D., He,Y.D., Garrett-Engele,P., McDonagh,P.D., Loerch,P.M., Leonardson,A., Lum,P.Y., Cavet,G. et al. (2001) Experimental annotation of the human genome using microarray technology. Nature, 409, 922-927.
5. Shi,Y. (2003) Mammalian RNAi for the masses. Trends Genet., 19 9-12.
6. Rothstein,R. (1991) Targeting, disruption, replacement, and allele rescue: Integrative DNA transformation in yeast. Methods Enzymol., 194, 281-301.
7. Rothstein,R.J. (1983) One-step gene disruption in yeast. Methods Enzymol., 101, 202-211.
8. Sato,T.N. (1999) Gene trap, gene knockout, gene knock-in, and transgenics in vascular development. Thromb. Haemost., 82, 865-869.
9. Rossant,J. and McKerlie,C. (2001) Mouse-based phenogenomics for modelling human disease. Trends Mol. Med., 7, 502-507.
10. Parks,R.J. (2000) Improvements in adenoviral vector technology: overcoming barriers for gene therapy. Clin. Genet., 58, 1-11.
11. Elbashir,S.M., Harborth,J., Lendeckel,W., Yalcin,A., Weber,K. and Tuschl,T. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498.
12. Sui,G., Soohoo,C., Affar el,B., Gay,F., Shi,Y. and Forrester,W.C. (2002) A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl Acad. Sci. USA, 99, 5515-5520.
13. Yu,J.Y., DeRuiter,S.L. and Turner,D.L. (2002) RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc. Natl Acad. Sci. USA, 99, 6047-6052.
14. Brummelkamp,T.R., Bernards,R. and Agami,R. (2002) Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell, 2, 243-247.
15. Davidson,B.L. and Paulson,H.L. (2004) Molecular medicine for the brain: silencing of disease genes with RNA interference. Lancet Neurol., 3, 145-149.
16. Muruve,D.A., Cotter,M.J., Zaiss,A.K., White,L.R., Liu,Q., Chan,T., Clark,S.A., Ross,P.J., Meulenbroek,R.A.,Maelandsmo,G.M. et al. (2004) Helper-dependent adenovirus vectors elicit intact innate but attenuated adaptive host immune responses in vivo. J. Virol., 78, 5966-5972.
17. Gonzalez-Santos,J.M., Wang,A., Jones,J., Ushida,C., Liu,J. and Hu,J. (2002) Central region of the human splicing factor hprp3p interacts with hprp4p. J. Biol. Chem., 277, 23764-23772.
18. Wang,A., Forman-Kay,J., Luo,Y., Luo,M., Chow,Y.H., Plumb,J., Friesen,J.D., Tsui,L.C., Heng,H.H., Woolford,J.L.,Jr and Hu,J. (1997) Identification and characterization of human genes encoding Hprp3p and Hprp4p, interacting components of the spliceosome. Hum. Mol. Genet. 6, 2117-2126.
19. Koehler,D.R., Chow,Y.H., Plumb,J., Wen,Y., Rafii,B., Belcastro,R., Haardt,M., Lukacs,G.L., Post,M., Tanswell,A.K. and Hu,J. (2000) A human epithelium-specific vector optimized in rat pneumocytes for lung gene therapy. Pediatr. Res., 48, 184-190.
20. Chow,Y.H., O'Brodovich,H., Plumb,J., Wen,Y., Sohn,K.J., Lu,Z., Zhang,F., Lukacs,G.L., Tanswell,A.K., Hui,C.C. et al. (1997) Development of an epithelium-specific expression cassette with human DNA regulatory elements for transgene expression in lung airways. Proc. Natl Acad. Sci. USA, 94, 14695-14700.
21. Sandig,V., Youil,R., Bett,A.J., Franlin,L.L., Oshima,M., Maione,D., Wang,F., Metzker,M.L., Savino,R. and Caskey,C.T. (2000) Optimization of the helper-dependent adenovirus system for production and potency in vivo. Proc. Natl Acad. Sci. USA, 97, 1002-1007.
22. Ng,P., Parks,R.J. and Graham,F.L. (2002) Preparation of helper-dependent adenoviral vectors. Methods Mol. Med., 69, 371-388.
23. Toietta,G., Koehler,D.R., Finegold,M., Lee,B., Hu,J. and Beaudet,A.L. (2003) Reduced inflammation and improved airway expression using helper-dependent adenoviral vectors with a K18 promoter. Mol. Ther. 7, 649-658.
24. Gerlier,D. and Thomasset,N. (1986) Use of MTT colorimetric assay to measure cell activation. J. Immunol. Methods, 94, 57-63.
25. Tsirigotis,M., Thurig,S., Dube,M., Vanderhyden,B.C., Zhang,M. and Gray,D.A. (2001) Analysis of ubiquitination in vivo using a transgenic mouse model. Biotechniques, 31, 120-126.
26. Dunn,K.C., Aotaki-Keen,A.E., Putkey,F.R. and Hjelmeland,L.M. (1996) ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp. Eye Res., 62, 155-169.
27. Horowitz,D.S., Kobayashi,R. and Krainer,A.R. (1997) A new cyclophilin and the human homologues of yeast Prp3 and Prp4 form a complex associated with U4/U6 snRNPs. RNA, 3, 1374-1387.
28. Lauber,J., Plessel,G., Prehn,S., Will,C.L., Fabrizio,P., Groning,K., Lane,W.S. and Luhrmann,R. (1997) The human U4/U6 snRNP contains 60 and 90 kD proteins that are structurally homologous to the yeast splicing factors Prp4p and Prp3p. RNA, 3, 926-941.
29. Behrens,S.E. and Luhrmann,R. (1991) Immunoaffinity purification of a [U4/ U6.U5] tri-snRNP from human cells. Genes Dev., 5, 1439-1452.
30. Chakarova,C.F., Hims,M.M., Bolz,H., Abu-Safieh,L., Patel,R.J., Papaioannou,M.G., Inglehearn,C.F., Keen,T.J., Willis,C., Moore,A.T. et al. (2002) Mutations in HPRP3, a third member of pre-mRNA splicing factor genes, implicated in autosomal dominant retinitis pigmentosa. Hum. Mol. Genet., 11, 87-92.
31. Anthony,J.G., Weidenhammer,E.M. and Woolford,J.L.,Jr (1997) The yeast Prp3 protein is a U4/U6 snRNP protein necessary for integrity of the U4/ U6 snRNP and the U4/U6.U5 tri-snRNP. RNA, 3, 1143-1152.
32. Barrett,N.L., Li,X. and Carmichael,G.G. (1995) The sequence and context of the 5′ splice site govern the nuclear stability of polyoma virus late RNAs. Nucleic Acids Res., 23, 4812-4817.
33. Ghogawala,Z., Choi,E., Daly,K.R., Blanco,L.R., Griffith,I.J. and Glimcher,L.H. (1989) An intronic 10-base-pair deletion in a class II A beta gene affects RNA processing. Mol. Cell. Biol., 9, 4402-4408.
34. Blencowe,B.J. and Ouzounis,C.A. (1999) The PWI motif: A new protein domain in splicing factors. Trends Biochem. Sci., 24, 179-180.
35. Rappsilber,J., Ajuh,P., Lamond,A.I. and Mann,M. (2001) SPF30 is an essential human splicing factor required for assembly of the U4/U5/U6 tri-small nuclear ribonucleoprotein into the spliceosome. J. Biol. Chem., 276, 31142-31150.
36. Zhou,H., Pastore,L. and Beaudet,A.L. (2002) Helper-dependent adenoviral vectors. Methods Enzymol., 346, 177-198.
37. Cao,H., Koehler,D.R. and Hu,J. (2004) Adenoviral vectors for gene replacement therapy. Viral Immunol., 17, 327-333.
38. St George,J.A. (2003) Gene therapy progress and prospects: Adenoviral vectors. Gene Ther., 10, 1135-1141.
39. Palmer,D. and Ng,P. (2003) Improved System for helper-dependent adenoviral vector production. Mol. Ther., 8, 846-852.
40. Deery,E.C., Vithana,E.N., Newbold,R.J., Gallon,V.A., Bhattacharya,S.S., Warren,M.J., Hunt,D.M. and Wilkie,S.E. (2002) Disease mechanism for retinitis pigmentosa (RP11) caused by mutations in the splicing factor gene PRPF31. Hum. Mol. Genet., 11, 3209-3219.
41. Vithana,E.N., Abu-Safieh,L., Allen,M.J., Carey,A., Papaioannou,M., Chakarova,C., Al-Maghtheh,M., Ebenezer,N.D., Willis,C., Moore,A.T. et al.(2001) A human homolog of yeast pre-mRNA splicing gene, PRP31, underlies autosomal dominant retinitis pigmentosa on chromosome 19q13.4 (RP11). Mol. Cell, 8, 375-381.
42. Wang,L., Ribaudo,M., Zhao,K., Yu,N., Chen,Q., Sun,Q. and Wang,Q. (2003) Novel deletion in the pre-mRNA splicing gene PRPF31 causes autosomal dominant retinitis pigmentosa in a large Chinese family. Am. J. Med. Genet. A, 121, 235-239.
43. Achsel,T., Ahrens,K., Brahms,H., Teigelkamp,S. and Luhrmann,R. (1998) The human U5-220kD protein (hPrp8) forms a stable RNA-free complex with several U5-specific proteins, including an RNA unwindase, a homologue of ribosomal elongation factor EF-2, and a novel WD-40 protein. Mol. Cell. Biol., 18, 6756-6766.
44. Brown,J.D. and Beggs,J.D. (1992) Roles of PRP8 protein in the assembly of splicing complexes. EMBO J., 11, 3721-3729.
45. Ali,R.R., Reichel,M.B., Thrasher,A.J., Levinsky,R.J., Kinnon,C., Kanuga,N., Hunt,D.M. and Bhattacharya,S.S. (1996) Gene transfer into the mouse retina mediated by an adeno-associated viral vector. Hum. Mol. Genet., 5, 591-594.